8 hours Oncolytics Biotech (ONCY) Upgraded to Buy: What Does It Mean for the Stock? Zacks

Oncolytics Biotech (ONCY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company’s earnings prospects. This might drive the stock higher in the near term.